Publications by authors named "S Brosseau"

Claim this Profile
M
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial.
Guénaëlle Levallet, Christian Creveuil, Alexandre Léger-Vigot, Solenn Brosseau, Claire Danel

Transl Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioengineering a Patient-Derived Vascularized Lung Tumor-on-Chip Model to Decipher Immunomodulation by the Endothelium.
Christine Lansche, Ségolène Ladaigue, Giacomo Gropplero, Nicolas Zimmermann, Martin Nurmik, Solenn Brosseau

Adv Healthc Mater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer.
S Brosseau, P Abreu, C Bouchez, L Charon, Y Kieffer

Mol Cell Biochem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip.
Irina Veith, Martin Nurmik, Arianna Mencattini, Isabelle Damei, Christine Lansche, Solenn Brosseau

Cell Rep Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial.
Guénaëlle Levallet, Fatéméh Dubois, Nicolas Elie, Christian Creveuil, Solenn Brosseau

Lung Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis